Back to Search Start Over

Supplemental Figure 4 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Authors :
Zigang Dong
Ann M. Bode
Young Il Yeom
Kanamata Reddy
Sung-Hyun Kim
Sung-Young Lee
Ji Won Jung
Hee Eun Kang
Souren Paul
Sun Chul Kang
Jong-Eun Kim
Eun Jin Cho
Hanyong Chen
Jung-Hyun Shim
Angelo Pugliese
Yong-Yeon Cho
Myoung Ok Kim
Do Young Lim
Naomi Oi
Mee-Hyun Lee
Eunmiri Roh
Dong Joon Kim
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

The effect of herbacetin on cell cycle. The effect of herbacetin or DFMO on cell cycle was determined using HCT116, DLD1 or HT29 colon cancer cells. Cells were treated with herbacetin or DFMO for 48 h in medium supplemented with 10% FBS and then cells were serum starved for 24 h in medium supplemented with 0.5% FBS. Cells were stained with propidium iodide (PI) and cell cycle was analyzed by Fluorescence Activated Cell Sorting (FACS). All data are represented as mean values {plus minus} S.D. of triplicate values from 3 independent experiments. The asterisk (*) indicates a significant effect (p < 0.05) of herbacetin or DFMO compared to untreated control.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....2c97e537f6aedfe8e8a7ed1abdf1eb90
Full Text :
https://doi.org/10.1158/0008-5472.22408955.v1